Search
Novo Nordisk Renamed to Novo, Fully Competing for Market Share in Weight-Loss Drugs
3 day ago /
Read about 0 minute
Author：小编
On September 13, Danish pharmaceutical company Novo Nordisk announced an update to its brand name to 'Novo' and a reshaping of its corporate culture, aiming to regain market share in weight-loss drugs and open a new chapter in development. Currently, Novo Nordisk is facing fierce competition from Eli Lilly and Company, while investors are pressuring it to launch new blockbuster drugs.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
